RAUDER
This release updates the previous release that posted earlier on Tuesday 6, 2024 to add more information.
PANAMA CITY, PANAMA / ACCESSWIRE / February 8, 2024 / The forum focused on promoting public health policies based on human rights and scientific evidence.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.• Panels addressed the need for legal access to reduced-risk alternatives, such as electronic cigarettes, for millions of smokers.
• Forum's participants signed a manifesto calling on COP10 delegates to avoid prohibition and look at scientific evidence and consumers' perspectives.
Razón Autonomía Derecho A.C, RAUDER, a non-profit civil association that advocates for human rights, personal autonomy, and the free development of personality, organized the "2nd Latin American Nicotine and Risk Reduction Forum: Science, Regulation, and Activism" that took place today in Panama City. The objective was to analyze and discuss the crucial role of reduced-risk alternatives in the fight against tobacco.
The event brought together legislators, experts, doctors, scientists, and activists from across the globe. They emphasized the importance of developing public policies that aim towards harm reduction and respect for human rights, and called for a humane and effective approach, that respects consumers' rights and provides safe, science-based regulated options.
They shared different perspectives around studies and relevant practices from various countries on how alternatives such as vapor products can significantly contribute to harm reduction in smoking. Participants emphasized that their prohibition in countries such as Mexico, Brazil and Panama, has led to an increase in illegal trade and limits smokers' options to access safer alternatives.
"It is essential to recognize and regulate vapor products as reduced-risk alternatives. Prohibition not only prevents smokers from legal options but drives the black market, and gives easier access to minors, besides, all the other negative consequences that it implies," explained Rafael Lara Liy, RAUDER's director.
Doctor Marina Hoyo, a forum's panelist, said: "As health professionals, we have a responsibility to stay up to date, analyze, understand, and question the evidence. But we also need to approach our patient care from a position of empathy towards people seeking to improve their health. That's why we must consider alternatives that reduce risks. This is the foundation of a therapeutic bond that aims to truly help the individual and not stigmatize them, but rather try to alleviate their condition."
Víctor Manuel Salcedo, member of the Chamber of Representatives of Colombia, explained: "Whenever there is a health risk, regulation is necessary. We, as legislators, have the responsibility to act immediately. Our experience indicates that we should regulate, but not prohibit."
The case of other countries, such as Brazil, was also discussed. In Brazil, the ban on vapor products since 2009 has led to an uncontrolled and unsanitary illegal market, affecting millions of smokers, according to Juan José Cirión Lee, President of the organization "México y el Mundo Vapeando." We urge the Brazilian National Health Surveillance Agency (ANVISA) not to miss the opportunity to regulate alternative nicotine consumption products, considering their potential for risk reduction and respect for human rights," he added.
Studies show a significant reduction in smoking rates through reduced-risk alternatives. "The results of studies in Sweden are a clear example of what can be achieved with reduced-risk alternatives. In just 15 years, Sweden has reduced its smoking rates from 15% to 5.6% and has achieved a mortality rate from tobacco-related diseases 39.6% lower than the EU average. This success is attributed to the accessibility, acceptability, and affordability of safer alternatives, combined with balanced regulations and awareness campaigns," explained Roberto Sussman, Researcher at the UNAM Institute of Nuclear Sciences in Mexico.
RAUDER has created an online petition to strengthen the collective voice in defense of human rights, health, and legal access to nicotine alternatives. Those interested in signing the petition or supporting the cause can do so by visiting the dedicated space on the Change.org platform.
The event ended with a manifest that demands all Latin American governments to avoid prohibitions and develop science-based regulatory frameworks. "Our goal is to ensure that smokers have access to less harmful alternatives as part of a comprehensive strategy to reduce the impact of smoking on public health and that our voices are heard. This perspective is especially relevant in the context of the Tenth Conference of the Parties to the WHO Framework Convention on Tobacco Control (COP 10), taking place this week in Panama," added Rafael Lara, Director of RAUDER.
"It is important to emphasize that we share the fundamental goal of protecting public health. We advocate for the voices of consumers to be considered in discussions and decision-making that significantly impact their human rights and global health," Lara emphasized.
About RAUDER
RAUDER, short for Razón, Autonomía y Derecho, A.C., is a non-profit organization composed of experts in various fields of knowledge. Their mission is to promote and defend human rights and their respect in the daily life of society. The organization aims to influence society and public policies with the banner of respect for human rights in all aspects of social development, providing citizens with clarity about which rights they can assert concerning their governing authorities.
PRESS CONTACT:
Abroad: alejandro@nimbus.mx
Contact Information
ALEJANDRO DURAN
PR DIRECTOR
alejandro@nimbus.mx
+525534467248
SOURCE: RAUDER
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Loar Announces Pricing of Upsized Public Offering10.12.2024 23:40:00 CET | Press release
WHITE PLAINS, NY / ACCESSWIRE / December 10, 2024 / Loar Holdings Inc. (NYSE:LOAR) ("Loar"), announced today the pricing of its upsized public offering of 5,750,000 shares of its common stock, including 1,897,500 shares offered by certain stockholders and 3,852,500 shares offered by Loar at $85.00 per share. The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 862,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on December 12, 2024, subject to customary closing conditions. Loar intends to use the net proceeds from this offering for repayment of borrowings outstanding under its credit agreement and, to the extent of any remaining proceeds, for general corporate purposes, including working capital. Loar will not receive any of the proceeds from the sale of common stock offered by the selling stockholders, including any common stock sold pursuant to any
PHYLA Announces a Series of International Collaborations With the University of Bradford and UPM and a Significant Government-Supported Land Regeneration Project in the Gambia10.12.2024 14:00:00 CET | Press release
LONDON, UK PHYLA and the University of Bradford join forces to develop marketable compounds, cosmetics and superfood products from the pongamia plant PHYLA has entered into a commercial agreement with the University of Bradford to develop marketable bio-compounds for cosmetics and superfood products derived from the pongamia (oil tree) plant which are cultivated in PHYLA's land regeneration projects. The partnership aims to leverage PHYLA's existing IP by applying specific extraction technologies which maximise the yield and value of bio-compounds and other plant-based products. Phyla's Pongamia Pods Phyla's high-density pongamia pod cluster Professor Anant Paradkar, Director of The Centre for Pharmaceutical Engineering Science (CPES) at the University of Bradford, commented: "We are thrilled to collaborate with PHYLA to advance the development of plant-based products. Our Centre has a long-standing commitment to green and sustainable extraction technologies, and this partnership align
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections10.12.2024 07:30:00 CET | Press release
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI). VisiRose, a newly launched company of Provectus Biopharmaceuticals (OTCQB:PVCT) and the University, is focused on commercializing this innovative ocular research by combining a formulation of Provectus's pharmaceutical-grade bioactive synthetic small molecule Rose Bengal Sodium (RBS) and BPEI's light-based medical device to treat eye infections caused by bacteria, fungi, and parasites. RB PDAT offers a potential solution to the growing global problem of antimicrobial resistance (AMR), providing a broad-spectrum ocular thera
Young Girl Discovers a 3,500-year-old Egyptian Amulet9.12.2024 07:40:00 CET | Press release
During a family trip near an archaeological site in Hod Hasharon, 12-year-old Dafna Filshteiner found an ancient scarab. LONDON, UK / ACCESSWIRE / December 9, 2024 / Dafna Filshteiner, age 12, was recently hiking below the ancient site of Tel Qana in Hod Hasharon, when suddenly, to her surprise, she discovered an unusual find a beetle-like stone used as an Egyptian amulet about 3,500 years ago. "I was looking down at the ground to find porcupine needles and smooth pebbles," she says. "And suddenly I picked up an interesting stone. I showed it to my mother, and she said it was just an ordinary stone or a bead. But then I saw a decoration and stubbornly insisted it was more than that, so we searched on the Internet. There, we identified more photos of stones similar to what we had found. We realized that it was something special and immediately called the Antiquities Authority." The family turned to Mor Wiesel, an archaeologist at the Israel Antiquities Authority, who thanked Dafna and h
Loar Announces Launch of Public Offering9.12.2024 06:30:00 CET | Press release
WHITE PLAINS, NY / ACCESSWIRE / December 9, 2024 / Loar Holdings Inc. (NYSE:LOAR) ("Loar") announced today that it has launched the roadshow for the public offering of 4,750,000 shares of its common stock, including 1,583,333 shares offered by certain stockholders and 3,166,667 shares offered by Loar. In addition, such selling stockholders expect to grant the underwriters a 30-day option to purchase up to 712,500 additional shares of common stock at the public offering price, less underwriting discounts and commissions. Loar intends to use the net proceeds from this offering for repayment of borrowings outstanding under its credit agreement and, to the extent of any remaining proceeds, for general corporate purposes, including working capital. Loar will not receive any of the proceeds from the sale of common stock offered by the selling stockholders, including any common stock sold pursuant to any exercise by the underwriters of their option to purchase additional shares. Jefferies and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom